Mission
Keep every family away from liver cancer
Founded in 1998 in Ulanqab, Inner Mongolia, Furui is headquartered in Beijing with subsidiaries across France, the United States, Germany, Spain, the United Kingdom, Italy, Singapore, and Hong Kong. The company went public on the Shenzhen Stock Exchange’s ChiNext board in 2010 under the ticker 300049. Furui specializes in managed healthcare services, building its core value around three key pillars: screening and managing high-risk liver cancer populations, standardized secondary prevention treatments, and outcome-based payment models tied to treatment effectiveness.
Managed care model
Building on the standardized "antiviral and antifibrotic" therapy with traditional Chinese medicine, Furui innovates a value-based payment model tied to treatment outcomes.
Leveraging research on FibroScan and aMAP for high-risk population screening, Furui establishes new liver cancer screening standards for primary care institutions and national occupational health guidelines.
Grounded in extensive real-world studies, Furui advances a new secondary prevention strategy for liver cancer.
Corporate Vision
Establish a global consensus on liver fibrosis and create a professional managed care group.
Corporate Mission
Keep every family away from liver cancer
Development History
Honors and Certificates
Furui won the 2024 Medical and Health Corporate Responsibility Model Award at the 14th Philanthropy Festival
The "Excellent Case of Corporate Social Responsibility in the Medical Field" award at the 5th Chinese Physician Assembly for Humanity
Furui won the "2024 Outstanding Medical Technology Innovation Award" at the 13th CFS Finance Summit
Furui won Baidu Health's 2024 Innovation and Development Award
Furui won the award of Philanthropy Festival for twelve consecutive years
Furui received the highest evaluation rating of "A" in the 2023–2024 Information Disclosure Assessment for ChiNext-listed Companies on the Shenzhen Stock Exchang
FibroScan won the certificate of excellent domestic medical equipment product catalog: BOX/HANDY/PRO/Q
Selected Product (Service) for the 2024 Liver Disease Prevention and Treatment Recommended Products and Services Showcase Directory: BOX
China Red Cross Dedication Medal
2023 Corporate Social Responsibility Quality Case Award
Furui won the title of Top Ten Hard-core Technology Enterprises in 2024
My Favorite Listed Company Brands List
Compound Biejia Ruangan Tablets were selected as one of the 100 dominant varieties of traditional Chinese medicine based on evaluation evidence in China
JD Health "Emerging Brand" Award
2022 Traditional Chinese Medicine Innovation Contribution Award
Two awards: Project Award and Public Welfare Collective Award of the 12th Philanthropy Festival
Two awards: Project Award and Public Welfare Collective Award of the 11th Philanthropy Festival
2021 Ranking of Branded Chinese Traditional Patent Medicines with Clinical Value
